Signet Investment Advisory Group’s Novo Nordisk NVO Stock Holding History

Signet Investment Advisory Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Hold	21,600	–	–	0.46%	48
2026 Q1	$794K	Hold	21,600	–	–	0.36%	50
2025 Q4	$1.1M	Hold	21,600	–	–	0.51%	45
2025 Q3	$1.2M	Hold	21,600	–	–	0.58%	46
2025 Q2	$1.49M	Buy	21,600 +25	+0.1%	+$1.7K	0.77%	43
2025 Q1	$1.5M	Hold	21,575	–	–	0.76%	45
2024 Q4	$1.86M	Hold	21,575	–	–	0.95%	38
2024 Q3	$2.57M	Hold	21,575	–	–	1.29%	32
2024 Q2	$3.08M	Sell	21,575 -2,425	-10%	-$321K	1.65%	25
2024 Q1	$3.08M	Hold	24,000	–	–	1.68%	23
2023 Q4	$2.48M	Hold	24,000	–	–	1.49%	29
2023 Q3	$2.18M	Hold	24,000	–	–	1.45%	29
2023 Q2	$1.94M	Sell	24,000 -2,000	-8%	-$163K	1.28%	31
2023 Q1	$2.07M	Sell	26,000 -2,000	-7%	-$142K	1.43%	27
2022 Q4	$1.89M	Hold	28,000	–	–	1.34%	29
2022 Q3	$1.4M	Sell	28,000 -2,000	-7%	-$107K	1.08%	36
2022 Q2	$1.67M	Sell	30,000 -4,000	-12%	-$222K	1.16%	35
2022 Q1	$1.89M	Sell	34,000 -2,000	-6%	-$103K	1.14%	33
2021 Q4	$2.02M	Sell	36,000 -4,000	-10%	-$217K	1.15%	32
2021 Q3	$1.92M	Hold	40,000	–	–	1.21%	32
2021 Q2	$1.68M	Hold	40,000	–	–	1.08%	35
2021 Q1	$1.35M	Hold	40,000	–	–	1.04%	35
2020 Q4	$1.4M	Buy	+40,000	New	+$1.38M	1.1%	30
2019 Q4	$1.16M	Hold	40,000	–	–	1.07%	35
2019 Q3	$1.03M	Hold	40,000	–	–	1.05%	35
2019 Q2	$1.02M	Hold	40,000	–	–	1.06%	35
2019 Q1	$1.05M	Hold	40,000	–	–	1.11%	36
2018 Q4	$921K	Buy	+40,000	New	+$889K	1.03%	36

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Signet Investment Advisory Group's NVO Position: Q2 2026 in Review

Signet Investment Advisory Group held its Novo Nordisk (NVO) position steady in Q2 2026 at 21,600 shares worth $1.04M. The position accounts for 0.46% of the portfolio, ranked #48.

Signet Investment Advisory Group first reported a position in NVO in Q4 2018 and has held it in 28 quarters since. The position peaked at $3.08M in Q1 2024. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Signet Investment Advisory Group held 21,600 shares of Novo Nordisk worth $1.04M as of Q2 2026.
Signet Investment Advisory Group left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.46% of Signet Investment Advisory Group's portfolio in Q2 2026, its #48 holding.
Signet Investment Advisory Group first reported a position in Novo Nordisk in Q4 2018 and has held it in 28 quarters since.
Signet Investment Advisory Group's Novo Nordisk position peaked at $3.08M in Q1 2024.
580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Signet Investment Advisory Group's 13F filing for Q2 2026, filed 30 Jul 2026.